Biotricity Inc (BTCY) USD0.001

Sell:$0.64Buy:$0.64$0.02 (3.23%)

Prices delayed by at least 15 minutes
Sell:$0.64
Buy:$0.64
Change:$0.02 (3.23%)
Prices delayed by at least 15 minutes
Sell:$0.64
Buy:$0.64
Change:$0.02 (3.23%)
Prices delayed by at least 15 minutes

Company Information

About this company

Biotricity Inc. is a medical technology company focused on biometric data monitoring solutions. The Company developed its Bioflux COM technology, comprised of a monitoring device and software components. Its Bioflux and Biocore Pro are integrated electrocardiogram (ECG) device and software solutions for the COM market. The Biocore ECG reporting software allows doctors and labs to view a patient’s ECG data for monitoring and diagnostic purposes. The Bioflux and Biocore Pro platform has a built-in cellular chipset and a real-time embedded operating system which allows its technology to be utilized as an Internet of Things (IoT) platform. The Company has developed several technologies, including Bioheart, Biocare, and Biokit. Biokit is a remote patient monitoring kit that combines a blood pressure cuff, pulse oximeter and a digital thermometer into the Biocare platform to support the collection of additional biometrics for those patients with multiple conditions.

Key people

Waqaas Al-Siddiq
Chairman of the Board, President, Chief Executive Officer
John Ayanoglou
Chief Financial Officer
Jainal Bhuiyan
Independent Director
Ronald Mcclurg
Independent Director
David A. Rosa
Independent Director
Click to see more

Key facts

  • EPIC
    BTCY
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Medical Equipment & Supplies
  • ISIN
    US09074H2031
  • Market cap
    $18.98m
  • Employees
    46
  • Shares in issue
    26.57m
  • Exchange
    Over The Counter
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.